本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edesa Biotech

2.44
+0.02501.04%
成交量:3,913.00
成交额:9,514.61
市值:1,713.67万
市盈率:-1.94
高:2.45
开:2.43
低:2.40
收:2.41
52周最高:5.00
52周最低:1.55
股本:703.76万
流通股本:428.26万
量比:0.51
换手率:0.09%
股息:- -
股息率:- -
每股收益(TTM):-1.2528
每股收益(LYR):-1.9297
净资产收益率:-69.64%
总资产收益率:-40.22%
市净率:3.49
市盈率(LYR):-1.26

数据加载中...

2019/06/11

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/11

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/11

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/11

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/10

重要事件披露

Current report, items 2.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, and 9.01
2019/05/30

重要事件披露

Current report, item 5.07
2019/05/08

重要事件披露

Current report, items 2.02 and 9.01
2019/05/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/03/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/03/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/03/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/03/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/03/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/03/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/03/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/03/08

重要事件披露

Current report, items 1.01, 3.02, 5.01, 5.02, and 9.01
2019/02/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/02/05

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/02/05

重要事件披露

Current report, items 2.02 and 9.01
2019/01/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals